Watch NHI. Know when insiders buy.
One email the day a filing lands. Free.
NHI
NATIONAL HEALTH INVESTORS INC
64.92
−1.43 −2.16%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
41
WATCH · shorts 41
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $3.2BP/E 18.8DIV YIELD 5.67%FCF YIELD —REV TTM $432.1M +23.9%NET INCOME $166.8M +16.7%NET DEBT $1.1B52W 63.96 – 91.02SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $121.3M | +33.8% | — | — | $55.7M | +50.5% | 1.15 | $65M | — | — | Aug 10 |
| Q1 2026 · Mar 31 | $115.1M | +28.9% | — | — | $40.1M | +17.4% | 0.82 | $53.4M | $109.4M | −$56M | May 4 |
| Q4 2025 · Dec 31derived | $105.8M | +23.4% | — | — | $38.2M | −11.7% | 0.80 | $67.7M | $143.3M | −$75.6M | Feb 26 |
| Q3 2025 · Sep 30 | $89.8M | +8.3% | — | — | $32.9M | +15.1% | 0.69 | $62.5M | — | — | Nov 6 |
| Q2 2025 · Jun 30 | $90.7M | +6.7% | — | — | $37M | +4.9% | 0.79 | $59.8M | — | — | Aug 10 |
| Q1 2025 · Mar 31 | $89.3M | +9.5% | — | — | $34.2M | +10.4% | 0.74 | $46.5M | $85.2M | −$38.7M | May 4 |
| Q4 2024 · Dec 31 | $85.8M | +7.9% | — | — | $43.2M | +34.9% | 0.96 | $57.6M | $110.8M | −$53.3M | Feb 26 |
| Q3 2024 · Sep 30 | $82.9M | +3.5% | — | — | $28.5M | −2.7% | 0.65 | $48.6M | — | — | Nov 6 |
| Q2 2024 · Jun 30 | $85M | — | — | — | $35.3M | — | 0.81 | $60.7M | — | — | Nov 6 |
| Q1 2024 · Mar 31 | $81.5M | — | — | — | $30.9M | — | 0.71 | $40.8M | — | — | Nov 6 |
| Q4 2023 · Dec 31 | $79.5M | — | — | — | $32M | — | 0.74 | $53.2M | — | — | Feb 26 |
| Q3 2023 · Sep 30 | $80.1M | — | — | — | $29.3M | — | 0.68 | $49.7M | — | — | Feb 25 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $375.6M | — | — | $142.2M | 37.9% | 3.02 | $236.6M | $294M | −$57.5M | — | $169.7M |
| FY2024 · to Dec 31 | $335.2M | — | — | $138M | 41.2% | 3.13 | $207.8M | $157.9M | $49.8M | $0 | $156.5M |
| FY2023 · to Dec 31 | $319.8M | — | — | $135.7M | 42.4% | 3.13 | $184.4M | $49.6M | $134.9M | $0 | $156.2M |
| FY2022 · to Dec 31 | $278.2M | — | — | $66.4M | 23.9% | 1.48 | $185.3M | $11M | $174.3M | $152M | $161.8M |
| FY2021 · to Dec 31 | $298.7M | — | — | $111.8M | 37.4% | 2.44 | $210.9M | $50.3M | $160.5M | $0 | $182.9M |
| FY2020 · to Dec 31 | $332.8M | — | — | $185.1M | 55.6% | 4.14 | $232.1M | $116.7M | $115.4M | $0 | $194.6M |
Every number comes from NATIONAL HEALTH INVESTORS INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.